Role of Liquid Chlorophyll As Adjuvant Therapy In Children With Beta Thalassemia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202404706815223

Enrollment

Registered

2024-04-26

Start date

2024-05-15

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haematological Disorders Paediatrics

Interventions

Placebo

Liquid chlorophyll

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children with ß- thalassemia aged 1 -18 years

Exclusion criteria

Exclusion criteria: 1.Children with ß- thalassemia who are not compliant with liquid chlorophyll therapy. 2.Children with ß- thalassemia who are allergic to liquid chlorophyll.

Design outcomes

Primary

Measure	Time frame
frequency of blood transfusion, CBC parameters, serum ferritin level in both groups	—

Secondary

Measure	Time frame
Liquid chlorophyll side effects	—

Countries

Egypt

Contacts

Public ContactIbrahim Badraia

Professor of Pediatrics

mohambadraia@gmail.com+201002169369

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026